Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

EPA:COVH - FR0000060303 - REIT

24 EUR
+0.3 (+1.27%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 42 industry peers in the Diversified REITs industry. COVH has only an average score on both its financial health and profitability. COVH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

COVH had positive earnings in the past year.
In the past year COVH had a positive cash flow from operations.
In multiple years COVH reported negative net income over the last 5 years.
COVH had a positive operating cash flow in each of the past 5 years.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

COVH has a Return On Assets (2.89%) which is in line with its industry peers.
The Return On Equity of COVH (5.88%) is better than 63.41% of its industry peers.
COVH's Return On Invested Capital of 3.68% is fine compared to the rest of the industry. COVH outperforms 60.98% of its industry peers.
COVH had an Average Return On Invested Capital over the past 3 years of 3.85%. This is in line with the industry average of 3.38%.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With an excellent Profit Margin value of 78.96%, COVH belongs to the best of the industry, outperforming 85.37% of the companies in the same industry.
COVH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 101.55%, COVH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
COVH's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COVH is destroying value.
Compared to 1 year ago, COVH has about the same amount of shares outstanding.
The number of shares outstanding for COVH has been increased compared to 5 years ago.
The debt/assets ratio for COVH is higher compared to a year ago.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.05, we must say that COVH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.05, COVH is in the better half of the industry, outperforming 65.85% of the companies in the same industry.
COVH has a debt to FCF ratio of 12.72. This is a negative value and a sign of low solvency as COVH would need 12.72 years to pay back of all of its debts.
COVH has a Debt to FCF ratio of 12.72. This is comparable to the rest of the industry: COVH outperforms 51.22% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
COVH has a Debt to Equity ratio (0.70) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Altman-Z 1.05
ROIC/WACC0.7
WACC5.29%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
COVH's Current ratio of 1.16 is amongst the best of the industry. COVH outperforms 85.37% of its industry peers.
A Quick Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
COVH has a better Quick ratio (1.16) than 85.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 241.67% over the past year.
Measured over the past years, COVH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.16% on average per year.
The Revenue has decreased by -5.26% in the past year.
COVH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.29% yearly.
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

The Earnings Per Share is expected to grow by 0.90% on average over the next years.
COVH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.55% yearly.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

COVH is valuated rather expensively with a Price/Earnings ratio of 17.39.
COVH's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.06, COVH is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.92, which indicates a correct valuation of COVH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH indicates a slightly more expensive valuation: COVH is more expensive than 68.29% of the companies listed in the same industry.
COVH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.39
Fwd PE 13.92
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COVH is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, COVH is valued a bit more expensive than 63.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.4
EV/EBITDA 17.37
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.77
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

COVH has a Yearly Dividend Yield of 6.33%, which is a nice return.
Compared to an average industry Dividend Yield of 5.48, COVH pays a bit more dividend than its industry peers.
COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 6.33%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

19.16% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
DP19.16%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (9/5/2025, 7:00:00 PM)

24

+0.3 (+1.27%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-16 2025-07-16
Earnings (Next)10-22 2025-10-22
Inst Owners31.29%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.79B
Analysts82.86
Price Target18.67 (-22.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.33%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.16%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.39
Fwd PE 13.92
P/S 14.55
P/FCF 16.4
P/OCF 10.37
P/B 1.08
P/tB 1.2
EV/EBITDA 17.37
EPS(TTM)1.38
EY5.75%
EPS(NY)1.72
Fwd EY7.18%
FCF(TTM)1.46
FCFY6.1%
OCF(TTM)2.31
OCFY9.64%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.74%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexcg growth 3Y33.75%
ROICexcg growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Debt/EBITDA 6.97
Cap/Depr 152.56%
Cap/Sales 51.52%
Interest Coverage 4.11
Cash Conversion 103.65%
Profit Quality 112.39%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.05
F-Score5
WACC5.29%
ROIC/WACC0.7
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.29%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%